BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21667556)

  • 1. [Current and future therapies for prophylaxis of thromboembolism in atrial fibrillation].
    Geisler T; Gawaz M
    MMW Fortschr Med; 2011 Apr; 153(15):27-30; quiz 31. PubMed ID: 21667556
    [No Abstract]   [Full Text] [Related]  

  • 2. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S; Ansell J
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New clinical perspectives in the management of oral direct anticoagulant agents].
    Marco P; Zamorano JL; Chana F; Llau JV
    Med Clin (Barc); 2014 Feb; 142(4):171-8. PubMed ID: 23866969
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gastrointestinal bleeding under treatment with new oral anticoagulants].
    Konturek P; Hess T
    MMW Fortschr Med; 2014 Feb; 156(2):50-2. PubMed ID: 24934056
    [No Abstract]   [Full Text] [Related]  

  • 5. [New anticoagulants in patients with atrial fibrillation].
    Diener HC; Weber R
    MMW Fortschr Med; 2013 May; 155(8):55-6, 58. PubMed ID: 24437140
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prophylaxis of thromboembolism in atrial fibrillation: new oral anticoagulants and left atrial appendage closure].
    Zeus T; Kelm M; Bode C
    Dtsch Med Wochenschr; 2015 Aug; 140(16):1213-5. PubMed ID: 26261929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Ahmad Y; Lip GY
    Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel anticoagulants for stroke prevention in atrial fibrillation].
    Baumhäkel M; Schirmer SH; Böhm M
    Dtsch Med Wochenschr; 2010 Nov; 135(46):2304-8. PubMed ID: 21064013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic treatment of atrial fibrillation: new insights.
    Le Heuzey JY
    Thromb Res; 2012 Oct; 130 Suppl 1():S59-60. PubMed ID: 23026665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Your patient needs antithrombotics, 2. What do the new substances offer? (interview by Dr. med. Peter Stiefelhagen)].
    Stiefelhagen P
    MMW Fortschr Med; 2013 Feb; 155(3):18. PubMed ID: 23573760
    [No Abstract]   [Full Text] [Related]  

  • 11. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atrial fibrillation: what the GP needs to know].
    Diener HC; Kaeufer T; Bode C
    MMW Fortschr Med; 2011 Sep; 153(38):44-7; quiz 48. PubMed ID: 21977796
    [No Abstract]   [Full Text] [Related]  

  • 13. [New oral anticoagulants: better than vitamin K antagonists?].
    Völler H; Alban S; Westermann D
    Internist (Berl); 2010 Dec; 51(12):1571-81. PubMed ID: 20809275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel oral anticoagulants and atrial fibrillation in the elderly].
    Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):34-40. PubMed ID: 24463062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.
    Lane DA; Wood K
    Circulation; 2015 Apr; 131(16):e412-5. PubMed ID: 25901074
    [No Abstract]   [Full Text] [Related]  

  • 16. New antithrombotic drugs and European approval processes.
    Marijon E; Fauchier L; Le Heuzey JY
    Lancet; 2011 Aug; 378(9792):662-3. PubMed ID: 21856473
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.
    Lenchus JD
    Hosp Pract (1995); 2013 Feb; 41(1):49-60. PubMed ID: 23466967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulant therapy in stroke patients].
    Kraglund KL; Husted SE; Modrau B; Grove EL
    Ugeskr Laeger; 2013 Jan; 175(5):265-8. PubMed ID: 23369327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I recently heard that there are alternative medications to the blood thinner warfarin. What are they, and how are they different?
    Duke Med Health News; 2012 Jan; 18(1):8. PubMed ID: 22324070
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prophylaxis of stroke and embolisms in atrial fibrillation--what is new in the guidelines?].
    Lewalter T
    MMW Fortschr Med; 2012 Mar; 154(5):50-2, 54. PubMed ID: 22624265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.